Ten patients were initially diagnosed with Isocitrate Dehydrogenase-1 (IDH-1)-mutant glioblastoma and would now be considered IDH-mutated astrocytoma WHO-grade 4. The gene discussed is IDH1; the disease is glioblastoma.